In the coming months, we will look at what research we need to know in order to measure progress on the path to a cure for MS, and how we can get there.
The first thing to remember is that there are a lot of unanswered questions about how MS is treated, how we manage it, and even the answer to the question of whether or not MS is even a disease in the first place.
MS is often thought of as a degenerative disease.
The medical community does not agree on how MS progresses, though it is often described as “degenerative.”
Some experts suggest that it is not a disease at all, but rather a “progressive neurodegeneration,” or progressive progressive loss of function in the brain, which can occur in many different ways.
The exact nature of MS has been a matter of intense debate over the years.
There are many different approaches to diagnosis and treatment for MS.
Some researchers have argued that MS is actually an autoimmune disease.
Others have argued for a combination of both approaches, and others have argued against one or the other.
MS has many names, and there are many types of MS.
The disease is classified as either a neurodegenative disease or an autoimmune disorder.
For example, people with multiple sclerosis are generally diagnosed with multiple disease, but there is a third category, in which there are only a few known MS cases.
The diagnosis of MS is not always easy.
There is often a wide range of possible causes of MS, as the disease is complex and affects a wide spectrum of tissues.
MS can affect different parts of the brain in different ways, and the disease may also manifest differently in different people.
In this article, we are going to look at how MS was treated and what it has taught us.
We will look first at the history of MS and how it is currently diagnosed.
Then, we’ll examine the current knowledge about the disease and how MS has changed over the last 30 years.
We’ll also discuss the implications of that change for our understanding of MS treatments and how they may change.
Finally, we’re going to take a look at some of the challenges that exist in the MS field today.
If you are new to the topic of MS research, this is the first of a series of articles that will discuss some of MS’ most important research questions and trends.
In the following article, the term “MS” will be used interchangeably with the word “insider threat,” or the threat that MS researchers may pose to their field and to our knowledge of the disease.
MS was first identified in 1930, and it was named after the 18th-century French physician who first observed symptoms of MS in a patient with rheumatoid arthritis.
Since then, it has been treated with various treatments, including a number of drugs that are currently used in the treatment of rheumatic disorders, including methotrexate and cisplatin.
MS treatment has progressed over time to include a wide variety of drugs, including anti-inflammatory drugs, anti-inflammatories, antiretroviral drugs, and a range of other treatments.
There has also been a lot more research being done into how MS may affect cognition, memory, and personality, and more research is being done on other neurological conditions, including Parkinson’s disease.
What is MS?
MS is an inflammatory disease caused by damage to the blood-brain barrier, which is a small tube of blood that connects the brain and spinal cord.
The blood vessels in the blood vessels, called the blood vessel head, are lined with an immune-forming protein called the granulocyte colony-stimulating factor (G-CSF), which binds to the T-cells, which are the brain’s immune cells.
When T-cell production is impaired, the immune system attacks these T- cells, which causes the disease to progress.
The immune system, in turn, attacks the cells in the cerebrospinal fluid (CSF) which surrounds the brain.
The CSF contains proteins called cytokines, which cause the immune cells to produce and release antibodies that bind to the foreign invaders.
These antibodies, called antibodies to foreign substances (ANTs), bind to and destroy the foreign foreign invaders, which then cause the disease, or inflammation, to progress further.
What are the main challenges in studying MS?
The main challenges for studying MS have been twofold: The first is the need to make the diagnosis of the condition, and to use the tools that are available to us.
Currently, there are no specific test that can determine if a person has MS, although there are some diagnostic tests.
For many people, there is no testing for other types of chronic conditions, such as diabetes, hypertension, and cancer.
The second challenge is the limited availability of testing.
MS treatments are only available in a few hospitals, clinics, and hospitals that specialize in treating MS.
There have been some recent attempts to develop more